Renal involvement in systemic lupus erythematosus: A study of 180 patients from a single center

Medicine

Volumn 78, Issue 3, 1999, Pages 148-166

  Le Thi Huong, Du ^b   Papo, Thomas ^c   Beaufils, Hélène ^c   Wechsler, Bertrand ^c   Blétry, Olivier ^a   Baumelou, Alain ^c   Godeau, Pierre ^c   Piette, Jean Charles ^c  

^a FOCH HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; STEROID;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CHILD; FEMALE; GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PERICARDITIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PSYCHOSIS; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; ANTI-INFLAMMATORY AGENTS; BIOPSY; CAUSE OF DEATH; CHILD; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREDNISONE; PREVALENCE; PROTEINURIA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0342439843     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199905000-00002     Document Type: Article

References (138)

1. Abeles M, Urman JD, Weinstein A, Lowenstein M, Rothfield NF. Systemic lupus erythematosus in the younger patient: Survival studies. J Rheumatol 7: 515-22, 1980.
2. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22: 1259-64, 1995.
3. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 22: 1265-70, 1995.
4. Adu D, Williams G, Taube D, Vilches AR, Turner DR, Cameron JS, Ogg CS. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Q J Med 141: 471-87, 1983.
5. Advisory Committee to the Renal Transplant Registry. Renal transplantation in congenital and metabolic diseases: A report from the ASC/NIH Renal Transplant Registry. JAMA 232: 143-53, 1975.
6. Amigo MC, Garcia-Torres R, Robles M, Bochichio T, Reyes PA. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 19: 1181-85, 1992.
7. Appel AE, Sablay LB, Golden RA, Barland P, Grayzel AI, Bank N. The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis. Am J Med 64: 274-83, 1978.
8. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 83: 877-85, 1987.
9. Arce-Salinas CA, Villa AR, Martinez-Rueda JO, Munoz L, Cardiel MH, Alcocer-Varela J, Alarcon-Segovia D. Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: A case-control study. Lupus 4: 197-203, 1995.
10. Asherson RA, Kant KS. Antiphospholipid antibodies and the kidney. J Rheumatol 20: 1268-72, 1993.
11. Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A, Lim K, Munoz-Rodriguez FJ, Levy RA, Boue F, Rossert J, Ingelmo M. "Catastrophic" antiphospholipid syndrome: Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77:195-207, 1998.
12. Austin HA, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis. Contributions of clinical and histologic data. Kidney Int 45: 544-50, 1994.
13. Austin HA, Klippel JA, Balow JE, Le Riche NGH, Steinberg AD, Plotz P, Decker JL. Therapy of lupus nephritis: Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314: 614-19, 1986.
14. Bakir AA, Levy PS, Dunea G. The prognosis of lupus nephritis in African-Americans: A retrospective analysis. Am J Kidney Dis 24: 159-71, 1994.
15. Baldwin DS, Lowenstein J, Rothfield NF, Gallo GR, McCluskey RT. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med 73: 929-42, 1970.
16. Balow JE, Austin HA, Muenz LR, Joyce KM, Antonovych TT, Kuppel JH, Steinberg AD, Plotz PH, Decker JL. Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N Engl J Med 311: 491-95, 1984.
17. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A. Lupus nephritis in children: A longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7: 924-29, 1996.
18. Barron KS, Sher MR, Silverman ED. Intravenous immunoglobulin therapy. Magic or black magic. J Rheumatol 19-S33: 94-97, 1992.
19. Becker BN, Fuchs H, Hakim R. Intravenous immune globulin in the treatment of patients with systemic lupus erythematosus and endstage renal disease. J Am Soc Nephrol 5: 1746-50, 1995.
20. Belmont HM, Storch M, Buyon J, Abramson S. New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: Efficacy in steroid unresponsive lupus nephritis. Lupus 4: 104-8, 1995.
21. Berden JHM. Lupus nephritis. Kidney Int 52: 538-58, 1997.
22. Bhathena DB, Sobel BJ, Migdal SD. Non-inflammatory renal microangiopathy of systemic lupus erythematosus ("lupus vasculitis"). Am J Nephrol 1: 144-59, 1981.
23. Bhuyan UN, Malaviya AN, Dash SC, Malhotra KK. Prognostic significance of renal angiitis in systemic lupus erythematosus (SLE). Clin Nephrol 20: 109-13, 1983.
24. Boelaert J, Morel-Maroger L, Mery JP. Renal insufficiency in lupus nephritis. Adv Nephrol 4: 249-61, 1974.
25. Boumpas DT, Austin HA, Vaughan EM, Klippel JH, Steinberg AD, Balow JE. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340: 741-45, 1992.
26. Burt RK, Traynor A, Ramsey-Goldman R. Hematopoietic stem-cell transplantation for systemic lupus erythematosus. N Engl J Med 337: 1777-78, 1997.
27. Cacoub P, Wechsler B, Piette JC, Beaufils H, Herreman G, Bletry O, Godeau P. Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis. Clin Exp Rheum 11: 479-85, 1993.
28. Caeiro F, Michielson MC, Berstein R, Hughes GRV, Ansell BM. Systemic lupus erythematosus in childhood. Ann Rheum Dis 40: 325-31, 1981.
29. Cairns SA, Acheson EJ, Corbett CL, Dosa S, Mallick NP, Lawler W, Williams G. The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis. Postgrad Med J 55: 723-27, 1979.
30. Cameron JS, Turner DR, Ogg C, Williams DG, Lessof MH, Chantler C, Leibowitz S. Systemic lupus erythematosus with nephritis: A long-term study. Q J Med 48: 1-24, 1979.
31. Celermajer DS, Thorner PS, Baumal R, Arbus G. Sex differences in childhood lupus nephritis. Am J Dis Child 138: 586-88, 1984.
32. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, de Ramon E, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ingelmo M, Hughes GRV, and the European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 72: 113-24, 1993.
33. Cheigh JS, Stenzel KH, Rubin AL, Chami J, Sullivan JF. Systemic lupus erythematosus in patients with chronic renal failure. Am J Med 75: 602-6, 1983.
34. Churg J, Bernstein J, Glassock RJ. Lupus nephritis. In: Churg J, Bernstein J, Glassock RJ, eds. Renal diseases. Classification and atlas of glomerular diseases. New York: Igaku Shoin, p 151, 1995.
35. Churg J, Sobin LH. Lupus nephritis. In: Renal diseases. Classification and atlas of glomerular diseases. Tokyo, Igaku Shoin, pp 127-49, 1982.
36. Ciruelo E, de la Cruz J, Lopez I, Gomez-Reino JJ. Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide. Arthritis Rheum 39: 2028-34, 1996.
37. Coplon NS, Diskin CJ, Petersen J, Swenson RS. The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med 308: 186-90, 1983.
38. Cunningham E, Provost T, Brentjens J, Reichlin M, Venuto RC. Acute renal failure secondary to interstitial nephritis. Arch Intern Med 138: 1560-61, 1978.
39. Decker JL, Klippel JH, Plotz PH, Steinberg AD. Cyclophosphamide or azathioprine in lupus glomerulonephritis: A controlled trial. Results at 28 months. Ann Intern Med 83: 606-15, 1975.
40. Descamps-Latscha B, Herbelin A. Long-term dialysis and cellular immunity: A critical survey. Kidney Int 43(Suppl 41): S135-42, 1993.
41. Descombes E, Droz D, Drouet L, Grunfeld JP, Lesavre P. Renal vascular lesions in lupus nephritis. Medicine (Baltimore) 76: 355-68, 1997.
42. Dinan HJ, Decker JL, Klippel JH, Balow JE, Plotz PH, Steinberg AD. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. Ann Intern Med 96: 728-36, 1982.
43. Donadio JV Jr, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: A long-term clinico-pathologic study. Lupus 4: 109-15, 1995.
44. Dooley MA, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int 51: 1188-95, 1997.
45. Durand JM, Lefevre P, Kaplanski G, Soubeyrand J. Thrombotic microangiopathy and the antiphospholipid syndrome. J Rheumatol 18: 1916-18, 1991.
46. Esdaile JM, Abrahamowicz M, Mackenzie T, Hayslett JP, Kashgarian M. The time-dependence of long-term prediction in lupus nephritis. Arthritis Rheum 37: 359-68, 1994.
47. Esdaile JM, Joseph L, Mackenzie T, Kaskgarian M, Hayslett JP. The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 21: 2046-51, 1994.
48. Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kaskgarian M. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis. A study of 87 patients and review of the literature. Q J Med 72: 779-833, 1989.
49. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50: 85-95, 1971.
50. Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 37: 1784-94, 1994.
51. Felson DT, Anderson J. Evidence of the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. N Engl J Med 311: 1528-33, 1984.
52. Fish AJ, Blau EB, Westberg NG, Burke BA, Vernier RL, Michael AF. Systemic lupus erythematosus within the first two decades of life. Am J Med 62: 99-117, 1977.
53. Font J, Cervera R, Navarro M, Pallares L, Lopez-Soto A, Vivancos J, Ingelmo M. Systemic lupus erythematosus in men: Clinical and immunological characteristics. Ann Rheum Dis 51: 1050-52, 1992.
54. Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X, Ingelmo M. Systemic lupus erythematosus in the elderly: Clinical and immunological characteristics. Ann Rheum Dis 50: 702-5, 1991.
55. Fraenkel L, Mackenzie T, Joseph L, Kaskgarian M, Hayslett JP, Esdaile JM. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis. J Rheumatol 21: 2052-57, 1994.
56. Ginzler E, Berg A. Mortality in systemic lupus erythematosus. J Rheumatol 14: 218-22, 1987.
57. Ginzler EM, Felson DT, Anthony JM, Anderson JJ. Hypertension increases the risk of renal deterioration in systemic lupus erythematosus. J Rheumatol 20: 1694-1700, 1993.
58. Ginzler EM, Nicastri AD, Chen CK, Friedman EA, Diamond HS, Kaplan D. Progression of mesangial and focal to diffuse lupus nephritis. N Engl J Med 291: 693-96, 1974.
59. Glidden RS, Mantzouranis EC, Borel Y. Systemic lupus erythematosus in childhood: Clinical manifestations and improved survival in fifty-five patients. Clin Immunol Immunopathol 29: 196-210, 1983.
60. Gonzalez-Crespo MR, Lopez-Fernandez JI, Usera G, Poveda MJ, Gomez-Reino JJ. Outcome of silent nephritis. Semin Arthritis Rheum 26: 468-76, 1996.
61. Goulet JR, Mackenzie T, Levinton C, Hayslett JP, Ciampi A, Esdaile JM. The longterm prognosis of lupus nephritis. The impact of the disease activity. J Rheumatol 20: 59-65, 1993.
62. Gourley MF, Austin HA III, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 125: 549-57, 1996.
63. Greisman SG, Thayaparan R-S, Godwin TA, Lockshin MD. Occlusive vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody. Arch Intern Med 151: 389-92, 1991.
64. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcon GS. Anticardiolipin antibodies in systemic lupus erythematosus: Clinical correlates, HLA associations, and impact on survival. J Rheumatol 20: 1684-93, 1993.
65. Hariharan S, Schroeder TJ, Carey MA, First MR. Renal transplantation in patients with systemic lupus erythematosus. Clin Transpl 6: 345-49, 1992.
66. Harris EN, Baguley E, Asherson RA, Hughes GRV. Clinical and serological features of the "antiphospholipid syndrome". Br J Rheumatol 26(Suppl 2): 19, 1987.
67. Harris EN, Williams E, Shah DJ, De Ceulaer K. Mortality of Jamaican patients with systemic lupus erythematosus. Br J Rheumatol 28: 113-17, 1989.
68. Hickman PL, Nolph KD, Jacobs R, Luger AM, Walker SE. Idiopathic focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus: An unusual combination. Am J Kidney Dis 23: 582-86, 1994.
69. Hill GS, Hinglais N, Tron F, Bach JF. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med 64: 61-79, 1978.
70. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB. Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 64: 285-95, 1985.
71. Houssiau FA, D'Cruz D, Vianna J, Hughes GRV. Lupus nephritis: The significance of serological tests at the time of biopsy. Clin Exp Rheumatol 9: 345-49, 1991.
72. Hussein MM, Mooij JMV, Roujouleh H. Cyclosporine in the treatment of lupus nephritis including 2 patients treated during pregnancy. Clin Nephrol 40: 160-63, 1993.
73. Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 24: 377-85, 1983.
74. Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller MA, Hess EV. Glomerular thrombosis in systemic lupus erythematosus: Prevalence and significance. Medicine (Baltimore) 60: 71-86, 1981.
75. Kaufman LD, Gomez Reino JJ, Heinicke MH, Gorevic PD. Male lupus: Retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature. Semin Arthritis Rheum 18: 189-97, 1989.
76. Kimberly RP, Lockshin MD, Sherman RL, Mouradian J, Saal S. Reversible "end-stage" lupus nephritis. Analysis of patients able to discontinue dialysis. Am J Med 74: 361-68, 1983.
77. Kincaid-Smith P, Fairley KF, Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 69: 795-815, 1988.
78. Koh ET, Boey ML. Late onset lupus: A clinical and immunological study in a predominantly Chinese population. J Rheumatol 21: 1463-67, 1994.
79. Koh WH, Fong KY, Boey ML, Feng PH. Systemic lupus erythematosus in 16 oriental males. A study of clinical and laboratory manifestations. Br J Rheumatol 33: 339-12, 1994.
80. Lachin JM, Lan SP. Termination of a clinical trial with no treatment group difference. The Lupus Nephritis Collaborative Study. Control Clin Trials 13: 62-79, 1992.
81. Le Thi Huong Du, Wechsler B, Piette JC, Cacoub P, Papo T, Sauvaget F, Bletry O, Chapelon C, Herreman G, Godeau P. Clinical features and outcome of childhood systemic lupus erythematosus. A retrospective study of 50 cases, Eur J Intern Med 4: 15-22, 1993.
82. Leaker B, McGregor A, Griffits M, Snaith M, Neild GH, Isenberg DA. Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis. Br J Rheumatol 30: 422-25, 1991.
83. Lee HS, Mujais SK, Kasinath BS, Spargo BH, Kate AI. Course of renal pathology in patients with systemic lupus erythematosus. Am J Med 77: 612-20, 1984.
84. Lentz RD, Michael AF, Friend PS. Membranous transformation of lupus nephritis. Clin Immunol Immunopathol 19: 131-38, 1981.
85. Levey AS, Lan SP, Corwin HL, Kasinath BS, Lachin J, Neilson EG, Hunsicker LG, Lewis EJ. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 116: 114-23, 1992.
86. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 326: 1372-79, 1992.
87. Lewis EJ, Kawala K, Schwartz MM. Histologic features that correlate with the prognosis of patients with lupus nephritis. Am J Kidney Dis 10: 192-97, 1987.
88. Lochhead KM, Pirsch JD, D'Alessandro AM, Knechtle SJ, Kalayoglu M, Sollinger HW, Belzer FO. Risk factors for renal allograft loss in patients with systemic lupus erythematosus. Kidney Int 49: 512-17, 1996.
89. Mahajan SK, Ordonez NG, Feitelson PJ, Lim VS, Spargo BH, Katz AI. Lupus nephropathy without clinical renal involvement. Medicine (Baltimore) 56: 493-501, 1977.
90. Mc Alindon T, Giannotta L, Taub N, D'Cruz D, Hughes GRV. Environmental factors predicting nephritis in systemic lupus erythematosus. Ann Rheum Dis 52: 720-24, 1993.
91. McCombs RP, Patferson JF. Factors influencing the course and prognosis of systemic lupus erythematosus. N Engl J Med 260: 1195-1204, 1959.
92. McLaughlin JR, Bombardier C, Farewell VT, Gladman DD, Urowitz MB. Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables. Arthritis Rheum 37: 559-67, 1994.
93. McLaughlin JR, Gladman DD, Urowitz MB, Bombardier C, Farewell VT, Cole E. Kidney biopsy in systemic lupus erythematosus. II. Survival analysis according to biopsy results. Arthritis Rheum 34: 1268-73, 1991.
94. Meija G, Zimmerman SW, Glass NR, Miller DT, Sollinger HW, Belzer FO. Renal transplantation in patients with systemic lupus erythematosus. Arch Intern Med 143: 2089-92, 1983.
95. Meislin AG, Rothfield N. Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 42: 37-19, 1968.
96. Mojcik CF, Klippel JH. End-stage renal disease and systemic lupus erythematosus. Am J Med 101: 100-107, 1996.
97. Morel-Maroger L, Mery JP, Droz D, Godin M, Verroust P, Kourilsky O, Richet G. Aspects evolutifs des glomerulonephrites lupiques. The course of lupus nephritis: Contribution in serial renal biopsies. Adv Nephrol 6: 79-118, 1976.
98. Moroni G, Banfi G, Ponticelli C. Clinical status of patients after 10 years of lupus nephritis. Q J Med 305: 681-89, 1992.
99. Neuman K, Wallace DJ, Azen C, Nessim S, Fichman M, Metzger AL, Klinenberg JR. Lupus in the 1980s: III. Influence of clinical variables, biopsy and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 25: 47-55, 1995.
100. Nossent HC, Henzen-Logmans SC, Wroom TM, Berden JH, Swaak TJ. Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum 33: 970-77, 1990.
101. Nossent HC, Swaak TJG, Berden JHM. Systemic lupus erythematosus after renal transplantation: Patient and graft survival and disease activity. Ann Intern Med 114: 183-88, 1991.
102. Nossent HC, Swaak TJG, Berden JHM. Systemic lupus erythematosus: Analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Am J Med 89: 169-74, 1990.
103. Nossent JC, Bronsveld W, Swaak TJG. Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow-up of renal function: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48: 810-16, 1989.
104. Nyberg G, Blohme I, Persson H, Olausson M, Svalander C. Recurrence of SLE in transplanted kidneys: A follow-up transplant biopsy study. Nephrol Dial Transplant 7: 116-23, 1992.
105. Oliet A, Hernandez E, Gallar P, Vigil A. High-dose intravenous gamma-globulin in systemic lupus erythematosus. Nephron 62: 465, 1992.
106. Pablos JL, Gutierrez-Millet V, Gomez-Reino JJ. Remission of lupus nephritis with cyclophosphamide and late relapses following withdrawal therapy. Scand J Rheumatol 23: 142-44, 1994.
107. Papo T, Faucher C, Le Thi Huong D, Beaufils H, Piette JC, Godeau P. Idiopathic focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus: An unusual combination. Am J Kidney Dis 24: 880-81, 1994.
108. Petri M, Perez-Gutthanns S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. Am J Med 91: 345-53, 1991.
109. Piette JC, Cacoub P, Wechsler B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 23: 357-66, 1994.
110. Pillemer SR, Austin HA, Tsokos GC, Balow JE. Lupus nephritis: Association between serology and renal biopsy measures. J Rheumatol 15: 284-88, 1988.
111. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthritis Rheum 21: 55-64, 1991.
112. Ponticelli C, Zucchelli P, Moroni G, Cagnoli L, Banfi G, Pasquali S. Long-term prognosis of diffuse lupus nephritis. Clin Nephrol 28: 263-71, 1987.
113. Rivera M, Marcen R, Pascual J, Naya MT, Orofino L, Ortuno J. Kidney transplantation in systemic lupus erythematosus nephritis. A one-center experience. Nephron 56: 148-51, 1990.
114. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schichsinger M, Fries JF, Wasner C, Medsger TA, Ziegler G, Klippel JH, Hadler NM, Albert D, Hess EV, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 25: 612-17, 1982.
115. Schwartz MM, Kawala KS, Corwin HL, Lewis EJ. The prognosis of segmental glomerulonephritis in systemic lupus erythematosus. Kidney Int 32: 274-79, 1987.
116. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ. Irre-productibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 21: 374-77, 1993.
117. Seleznick MJ, Friez JF. Variables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum 21: 73-80, 1991.
118. Sloan RP, Schwartz MM, Korbet SM, Borok RZ and the Lupus Nephritis Collaborative Study Group. Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. J Am Soc Nephrol 7: 299-305, 1996.
119. Steinberg AD, Steinberg SC. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34: 945-50, 1991.
120. Stock GG Jr, Krane NK. Treatment of end-stage renal disease due to lupus nephritis: Comparison of six patients treated with both peritoneal and hemodialysis. Adv Perit Dial 9: 147-51, 1993.
121. Stone JH, Amend WJ, Criswell LA. Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls. Arthritis Rheum 41: 1438-45, 1998.
122. Stone JH, Milward CL, Olson JL, Amend WJ, Criswell LA. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era. Arthritis Rheum 41: 678-86, 1998.
123. Strober S, Farinas MC, Field EH, Solovera JJ, Kiberd BA, Myers BD, Hoppe RT. Lupus nephritis after total lymphoid irradiation: Persistent improvement and reduction of steroid therapy. Ann Intern Med 107: 689-90, 1987.
124. Tan EM, Cohen AS, Friez JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-77, 1982.
125. Tanaka H, Akama H, Tominaga N, Oshima H, Ichikawa Y, Ikeda Y. Progressive renal failure in patients with lupus nephritis. J Intern Med 234: 257-62, 1993.
126. Tron F, Ganeval D, Droz D. Immunologically-mediated acute renal failure of non-glomerular origin in the course of systemic lupus erythematosus (SLE). Report of two cases. Am J Med 67: 529-32, 1979.
127. Valeri A, Radhakrishnan J, Estes D, Dagati V, Kopelman R, Pernis A, Flis R, Pirani C, Appel GB. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis. Clin Nephrol 42: 71-78, 1994.
128. Wacholtz MC, Lipsky PE. Treatment of lupus nephritis with CD5+, an immunoconjugate of an anti-CD5 monoclonal antibody and ricin A-chain. Arthritis Rheum 35: 837-39, 1992.
129. Wallace DJ, Podell TE, Weiner JM, Cox MB, Klinenberg JR, Forouzesh S, Dubois EL. Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980. Am J Med 72: 209-20, 1982.
130. Walravens P, Chase HP. The prognosis of childhood systemic lupus erythematosus. Am J Child Dis 130: 929-33, 1976.
131. Ward MM, Studenski S. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Arch Intern Med 152: 2082-88, 1992.
132. Ward MM, Studenski S. Systemic lupus erythematosus in men: A multivariate analysis of gender differences in clinical manifestations. J Rheumatol 17: 220-24, 1990.
133. Wernick RM, Smith DL, Houghton DC, Phillips DS, Booth JL, Runckel DN, Johnson DS, Brown KK, Gaboury CL. Reliability of histologic scoring for lupus nephritis: A community based evaluation. Ann Intern Med 119: 805-11, 1993.
134. Whitworth JA, Turner DR, Leibowitz S, Cameron JS. Focal segmental sclerosis or scarred focal proliferative glomerulonephritis? Clin Nephrol 9: 229-35, 1978.
135. Whiting-O'Keefe Q, Riccardi PJ, Henke JE, Shearn MA, Hopper J, Epstein WV. Recognition of information in renal biopsies of patients with lupus nephritis. Ann Intern Med 96: 723-27, 1982.
136. Wilson HA, Hamilton ME, Spyker DA, Brunner CM, O'Brien WM, Davis JS, Winfield JB. Age influences the clinical and serologic expression of systemic lupus erythematosus. Arthritis Rheum 24: 1230-35, 1981.
137. Yang LY, Chen WP, Lin CY. Lupus nephritis in children. A review of 167 patients. Pediatrics 94: 335-40, 1994.
138. Ziff M, Helderman JH. Dialysis and transplantation in end-stage lupus nephritis. N Engl J Med 308: 218-19, 1983.